BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29146630)

  • 1. A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination.
    Figueras A; Alsina-Sanchís E; Lahiguera Á; Abreu M; Muinelo-Romay L; Moreno-Bueno G; Casanovas O; Graupera M; Matias-Guiu X; Vidal A; Villanueva A; Viñals F
    Mol Cancer Ther; 2018 Feb; 17(2):532-543. PubMed ID: 29146630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.
    Gil M; Komorowski MP; Seshadri M; Rokita H; McGray AJ; Opyrchal M; Odunsi KO; Kozbor D
    J Immunol; 2014 Nov; 193(10):5327-37. PubMed ID: 25320277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.
    Wang J; Cai J; Han F; Yang C; Tong Q; Cao T; Wu L; Wang Z
    Int J Gynecol Cancer; 2011 Aug; 21(6):981-7. PubMed ID: 21738044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between chemokine axis CXCL12-CXCR4 and epithelial ovarian cancer].
    Guo Q; Wu XH; Lü YP; Yang B; Xu F; Zhang SJ
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(21):1677-80. PubMed ID: 24125682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
    Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L
    Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.
    Alsina-Sanchis E; Figueras A; Lahiguera Á; Vidal A; Casanovas O; Graupera M; Villanueva A; Viñals F
    Int J Cancer; 2016 Oct; 139(8):1894-903. PubMed ID: 27299695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system.
    Chiaramonte R; Colombo M; Bulfamante G; Falleni M; Tosi D; Garavelli S; De Simone D; Vigolo E; Todoerti K; Neri A; Platonova N
    Int J Biochem Cell Biol; 2015 Sep; 66():134-40. PubMed ID: 26235278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
    Jiang YP; Wu XH; Xing HY; DU XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
    Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
    Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a nitric oxide synthase inhibitor and a CXC chemokine receptor-4 antagonist on tumor growth and metastasis in a xenotransplanted mouse model of adenoid cystic carcinoma of the oral floor.
    Takaoka K; Hidaka S; Hashitani S; Segawa E; Yamamura M; Tanaka N; Zushi Y; Noguchi K; Kishimoto H; Urade M
    Int J Oncol; 2013 Sep; 43(3):737-45. PubMed ID: 23835861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion-derived epithelial cancer cells express hematopoietic markers and contribute to stem cell and migratory phenotype in ovarian carcinoma.
    Ramakrishnan M; Mathur SR; Mukhopadhyay A
    Cancer Res; 2013 Sep; 73(17):5360-70. PubMed ID: 23856249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer.
    Liu W; Wang Y; Wang H; Wang A
    Cell Biochem Biophys; 2014 Dec; 70(3):1893-900. PubMed ID: 25149650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
    Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of short hairpin RNA-induced CXCR4 silence on ovarian cancer cell.
    Chen HY; Wang JM; Wang HY; Zhang YX; Liu W; Pan L; Wang WH; Chen SF; Jin WG; Wang L
    Biomed Pharmacother; 2012 Oct; 66(7):549-53. PubMed ID: 22902648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
    Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
    Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CXCL12 in metastasis of human ovarian cancer.
    Jiang YP; Wu XH; Xing HY; DU XY
    Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells.
    Guo Z; Cai S; Fang R; Chen H; Du J; Tan Y; Ma W; Hu H; Cai S; Liu Y
    Colloids Surf B Biointerfaces; 2007 Oct; 60(1):1-6. PubMed ID: 17601710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
    Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
    Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
    Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
    Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.